Iterative Health
Accelerating clinical research with AI
CORE INFO
Iterative Health is a healthcare technology company that leverages AI to enhance the efficiency of clinical trials, focusing on areas like gastroenterology and cardiology. Their solutions are designed for pharmaceutical and biotech companies aiming to expedite the delivery of new therapies.
- Iterative Health recently closed a $77 million Series C funding round, led by Intrepid Growth Partners and GV (Google Ventures).businesswire.com
- The company has established a global network of over 100 research sites, achieving 2x faster site activation and 3x higher patient enrollment rates.businesswire.com
WHY WE WOULD WORK AT ITERATIVE HEALTH
Transform Patient Outcomes
Join a mission-driven team dedicated to accelerating clinical research and delivering life-changing therapies to patients faster, particularly in critical areas like gastroenterology and cardiology.
Innovative AI Technology
Work with cutting-edge AI-driven tools like SKOUT, which optimize clinical trials by analyzing endoscopic images and clinical data, setting new standards in precision medicine.
Collaborative Culture
Experience a supportive environment that values teamwork and personal growth, where employees uplift each other and achieve more together, embodying the core value of 'Team'.
Competitive Compensation
Benefit from a strong funding background with $264 million raised, ensuring competitive salaries and resources to attract top talent in the healthcare technology sector.
Global Impact
Be part of a global network with over 100 research sites across multiple continents, enhancing clinical trial efficiency and patient enrollment rates significantly.
Recognized Leadership
Join a company led by experienced professionals in clinical research and healthcare, including founders with deep expertise and a proven track record in transforming patient care.
MARKET AND TRACTION
TOTAL ADDRESSABLE MARKET
KEY METRICS
✦ KEY METRICNOTABLE CUSTOMERS
GROWTH TACTICS
COMPETITIVE ADVANTAGE
PRODUCT AND TECH
AI-Driven Precision Medicine
Iterative Health leverages AI-powered tools, such as SKOUT, to analyze endoscopic images and clinical data, optimizing clinical trials for conditions like inflammatory bowel disease and colorectal cancer. This technology enhances the efficiency of clinical research, ultimately improving patient outcomes.
Clinical Trial Optimization
The company focuses on embedding research directly into clinical care, which accelerates the delivery of novel therapeutics to patients. By streamlining clinical trial processes, Iterative Health significantly reduces startup timelines and increases patient enrollment rates.
Global Research Network
With over 100 research sites across North America, Europe, India, and Australia, Iterative Health has established a robust global network that facilitates faster site activation and higher patient enrollment. This extensive reach allows for more efficient clinical trials and broader access to diverse patient populations.
Expertise in Key Therapeutic Areas
Iterative Health specializes in clinical trials within gastroenterology, hepatology, obesity, and cardiology, utilizing deep expertise to enhance trial effectiveness. This focus on critical health areas ensures that the company is at the forefront of developing life-changing therapies.
Funding for Innovation
Having raised a total of $264 million across multiple funding rounds, including a recent $77 million Series C, Iterative Health is well-positioned to invest in technological advancements and expand its capabilities in clinical research. This financial backing supports the company's mission to transform patient care through innovative solutions.